Developing the Next Generation of Cannabinoid Therapeutics
Bold Strategy
Innovation in Research
Cannabinoid Therapeutics
THIS IS BRC.
About Us
BRC’s mission is to address unmet medical needs using innovative cannabinoid therapeutics — safely and effectively. We have full DEA compliance for botanically derived cannabinoids (phytocannabinoids).
BRC has developed proprietary poly-cannabinoids in titratable standardized dosages that are soon to enter the clinic.
Meet the Team
BRC’s management team is made up of experienced professionals from the pharmaceutical and regulated cannabinoid industries. This unique combination will be key for BRC to becoming the leading botanically derived cannabinoid therapeutics company in the United States.
190+ years
in the pharmaceutical industry
60+ years
in the regulated cannabinoid industry